Top-Analysts PicksInvest alongside the top 15% of Wall Street analysts.

Try Top-Picks
Blueprint Medicines Corporation Banner

Blueprint Medicines Corporation

BPMC Stock Analysis

Page title

Section title

Breakdown
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
Net Income
-40.285m-52.769m-72.495m-148.119m-236.642m-347.694m313.882M-644.085m-557.517m-506.984m
Depreciation & Amortization
622.000K948.000K1.582M1.578M4.246M5.259M6.559M6.479M11.735M11.665M
Change in Working Capital
1.752M14.411M39.886M14.441M31.240M9.725M-15.618m-23.680m-53.769m-41.128m
Operating Cash Flow
-35.400m-31.676m-24.513m-119.865m-175.009m-278.015m387.035M-298.653m-502.277m-436.847m
Capital Expenditure
-700.000k-4.883m-2.354m-15.512m-12.677m-14.013m-3.159m-261.241m-8.919m-16.062m
Free Cash Flow
-36.100m-36.559m-26.867m-135.377m-187.686m-292.028m383.876M-559.894m-511.196m-452.909m
Debt Repayment
-750.000k-1.806m-3.333m-2.583m-1.690m0.0000.0000.000-553.614m-97.933m
Dividends Paid
0.0000.0000.0000.0000.0000.0000.0000.0000.0000.000
Common Stock Issued
268.000K157.074M135.910M547.496M6.425M340.754M617.759M50.716M8.196M21.336M
Common Stock Repurchased
0.000259.000K928.000K5.271M0.0000.0000.0000.0000.0000.000
Net Change in Cash
45.253M115.467M-110.638m348.235M-331.643m46.175M570.200M-474.685m-90.215m-48.423m